4.7 Article

Exploring the impact of the recombinant Escherichia coli strain on defensins antimicrobial activity: BL21 versus Origami strain

期刊

MICROBIAL CELL FACTORIES
卷 21, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12934-022-01803-7

关键词

Host defense peptides; Escherichia coli; Strain; Recombinant protein

资金

  1. Ministerio de Ciencia, Innovacion y Universidades Grants [PID2019-107298RB-C21, PID2019-105622RB-I00, FUNFUTURE CEX2019-000917-S, SEV-2017-0706]
  2. Marato de TV3 foundation [201812-30-31-32-33]
  3. Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
  4. Generalitat de Catalunya (FI-AGAUR)
  5. INIA
  6. Ramon y Cajal fellowship from MINN [RyC-2017-22614]

向作者/读者索取更多资源

The emergence of antibiotic-resistant microorganisms has led to the development of alternative antimicrobial therapies such as host defense peptides (HDPs). In this study, the impact of different strains of Escherichia coli on the activity and stability of recombinant defensins was assessed. The results showed that the strain used as the cell factory had a clear impact on both the quantity and quality of the HDPs produced.
The growing emergence of microorganisms resistant to antibiotics has prompted the development of alternative antimicrobial therapies. Among them, the antimicrobial peptides produced by innate immunity, which are also known as host defense peptides (HDPs), hold great potential. They have been shown to exert activity against both Gram-positive and Gram-negative bacteria, including those resistant to antibiotics. These HDPs are classified into three categories: defensins, cathelicidins, and histatins. Traditionally, HDPs have been chemically synthesized, but this strategy often limits their application due to the high associated production costs. Alternatively, some HDPs have been recombinantly produced, but little is known about the impact of the bacterial strain in the recombinant product. This work aimed to assess the influence of the Escherichia coli strain used as cell factory to determine the activity and stability of recombinant defensins, which have 3 disulfide bonds. For that, an alpha-defensin [human alpha-defensin 5 (HD5)] and a beta-defensin [bovine lingual antimicrobial peptide (LAP)] were produced in two recombinant backgrounds. The first one was an E. coli BL21 strain, which has a reducing cytoplasm, whereas the second was an E. coli Origami B, that is a strain with a more oxidizing cytoplasm. The results showed that both HD5 and LAP, fused to Green Fluorescent Protein (GFP), were successfully produced in both BL21 and Origami B strains. However, differences were observed in the HDP production yield and bactericidal activity, especially for the HD5-based protein. The HD5 protein fused to GFP was not only produced at higher yields in the E. coli BL21 strain, but it also showed a higher quality and stability than that produced in the Origami B strain. Hence, this data showed that the strain had a clear impact on both HDPs quantity and quality.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据